Clinical presentations and molecular studies of invasive renal epithelioid angiomyolipoma

Clinical presentations and molecular studies of invasive renal epithelioid angiomyolipoma Int Urol Nephrol (2017) 49:1527–1536 DOI 10.1007/s11255-017-1629-4 UROLOGY - ORIGINAL PAPER Clinical presentations and molecular studies of invasive renal epithelioid angiomyolipoma 1 1 1 1 Cheng‑Keng Chuang · Hsin Chia Angela Lin · Han‑Yu Tasi · Kun‑Han Lee · 1 1 1 1 Yuting Kao · Fukai Leo Chuang · Ying‑Hsu Chang · Po‑Hung Lin · 1 1 Chung‑Yi Liu · See‑Tong Pang Received: 28 January 2017 / Accepted: 19 May 2017 / Published online: 25 May 2017 © Springer Science+Business Media Dordrecht 2017 Abstract Keywords Angiomyolipoma · Kidney · Next-generation Purpose Epithelioid angiomyolipoma (EAML) is a rare sequencing · Mammalian target of rapamycin · Metastasis variant of renal angiomyolipoma with malignant poten- tial, and the cytogenetic and clinical behavior of EAML remains a challenging issue. Introduction Methods We retrospectively analyze the clinical courses of five EAML, the use of everolimus on metastatic EAML, Renal angiomyolipoma (AML) is a benign mesenchymal and next-generation sequencing (NGS) and polymerase tumor composed of abnormal thick-walled blood vessels, chain reaction (PCR) studies to investigate the gene muta- smooth muscle cells and adipose tissue [1, 2]. Most renal tion of TSC and the impact of PI3K/Akt/mTOR signaling AMLs are sporadic, but some are associated http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png International Urology and Nephrology Springer Journals

Clinical presentations and molecular studies of invasive renal epithelioid angiomyolipoma

Loading next page...
 
/lp/springer_journal/clinical-presentations-and-molecular-studies-of-invasive-renal-0pu50gD7wa
Publisher
Springer Netherlands
Copyright
Copyright © 2017 by Springer Science+Business Media Dordrecht
Subject
Medicine & Public Health; Nephrology; Urology
ISSN
0301-1623
eISSN
1573-2584
D.O.I.
10.1007/s11255-017-1629-4
Publisher site
See Article on Publisher Site

Abstract

Int Urol Nephrol (2017) 49:1527–1536 DOI 10.1007/s11255-017-1629-4 UROLOGY - ORIGINAL PAPER Clinical presentations and molecular studies of invasive renal epithelioid angiomyolipoma 1 1 1 1 Cheng‑Keng Chuang · Hsin Chia Angela Lin · Han‑Yu Tasi · Kun‑Han Lee · 1 1 1 1 Yuting Kao · Fukai Leo Chuang · Ying‑Hsu Chang · Po‑Hung Lin · 1 1 Chung‑Yi Liu · See‑Tong Pang Received: 28 January 2017 / Accepted: 19 May 2017 / Published online: 25 May 2017 © Springer Science+Business Media Dordrecht 2017 Abstract Keywords Angiomyolipoma · Kidney · Next-generation Purpose Epithelioid angiomyolipoma (EAML) is a rare sequencing · Mammalian target of rapamycin · Metastasis variant of renal angiomyolipoma with malignant poten- tial, and the cytogenetic and clinical behavior of EAML remains a challenging issue. Introduction Methods We retrospectively analyze the clinical courses of five EAML, the use of everolimus on metastatic EAML, Renal angiomyolipoma (AML) is a benign mesenchymal and next-generation sequencing (NGS) and polymerase tumor composed of abnormal thick-walled blood vessels, chain reaction (PCR) studies to investigate the gene muta- smooth muscle cells and adipose tissue [1, 2]. Most renal tion of TSC and the impact of PI3K/Akt/mTOR signaling AMLs are sporadic, but some are associated

Journal

International Urology and NephrologySpringer Journals

Published: May 25, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off